[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]
Ashwin Varma, MD posts on X about japan, productivity, $6502t, texas instruments the most. They currently have XXXXX followers and XX posts still getting attention that total XXX engagements in the last XX hours.
Social category influence countries XXXXX% stocks XXXX%
Social topic influence japan 7.14%, productivity 7.14%, $6502t 3.57%, texas instruments 3.57%, norway 3.57%, sweden 3.57%, liquid 3.57%, korea 3.57%, south korea 3.57%, countries XXXX%
Top accounts mentioned or mentioned by @florianederer @straightedge @arpitrage @paulnovosad @dwarkeshsp @jacobkimmel @jackscn @afinetheorem @kingofthecoastt @rosenthaljon @jz281c @nikillinit @backshui @firstlast31415
Top assets mentioned Texas Instruments (TXN)
Top posts by engagements in the last XX hours
"E.g. US semiconductor makers were banned from entering Japan in the 1960s. Texas Instruments was allowed to only because they licensed ALL their IC patents which then got sublicensed to the entire Japanese semi industry (Toshiba NEC etc.)" @varma_ashwin97 on X 2025-07-17 21:08:37 UTC 2059 followers, XXX engagements
"And yes since 1970 it's been oil but Norway was rich before that" @varma_ashwin97 on X 2025-07-18 23:06:23 UTC 2058 followers, XXX engagements
"It makes sense if you are just a technology producer so your entire market is selling licenses - e.g. VOEST with the Basic Oxygen Process. But many times you are licensing to people who would very much like to outcompete you" @varma_ashwin97 on X 2025-07-17 21:08:38 UTC 2059 followers, XXX engagements
"Norway's economic performance is so strange. Despite having high labor productivity it's very hard to point out any technologically advanced industries in the country even compared to Sweden" @varma_ashwin97 on X 2025-07-18 23:06:08 UTC 2058 followers, XXX engagements
"@paulnovosad I think if you define the frontier by facts we know about the body sure. But thats not the same as the ability to practically intervene on disease. The latter has not advanced by leaps. 9/10 drug we take into clinical trials still fail and thats been true for XX years" @varma_ashwin97 on X 2025-07-18 22:00:22 UTC 2056 followers, XX engagements
"@dwarkesh_sp @jacobkimmel @jackscn For a perspective on this read:" @varma_ashwin97 on X 2025-07-19 01:47:00 UTC 2058 followers, XXX engagements
"@kingofthecoastt They also find that big plants accounted for more share of total output. I think that conclusion suggests that the big plants were not necessarily the efficient ones right" @varma_ashwin97 on X 2025-07-14 21:00:19 UTC 2050 followers, XX engagements
"@dwarkesh_sp @jacobkimmel @jackscn X. You should be *** extremely *** skeptical of this trend changing. It is a trend that has resisted an explosion of new knowledge and new techniques. Sequencing Crystallography HTS Biologics Recombinant Tools nothing has changed this" @varma_ashwin97 on X 2025-07-19 01:57:41 UTC 2058 followers, XXX engagements
"@paulnovosad There have been some truly amazing cases: Cystic Fibrosis HIV HCV gene therapies for specific monogenic diseases and CART for specific liquid cancers. But nonetheless the highest return medical innovations all were developed from 1940-1960" @varma_ashwin97 on X 2025-07-18 12:22:10 UTC 2056 followers, XXX engagements
"@dwarkesh_sp @jacobkimmel @jackscn X. Oh yes one more thing productivity maximizing = welfare maximizing Sometimes you want to sacrifice productivity for more shots on goal" @varma_ashwin97 on X 2025-07-19 23:32:03 UTC 2058 followers, XXX engagements
"I'll never understand company willingness to license know-how IP and general technology to erstwhile competitors in foreign countries. Japan and South Korea both leaned heavily on coercing technology licenses to transfer technology to its domestic firms for example" @varma_ashwin97 on X 2025-07-17 21:08:37 UTC 2059 followers, XXX engagements